Bayer’s Stivarga First Drug To Enter Brain Cancer Platform Trial

 
• By Kevin Grogan

GBM AGILE is the first global adaptive clinical trial platform for glioblastoma and the German group's liver and colorectal cancer drug will be the first of several therapies to be studied.

Desert
Looking to make advances in brain cancer • Source: Shutterstock

More from Anticancer

More from Therapy Areas